title: Clozapine's Effect on Recidivism Among Offenders with Mental Disorders.
abstract: Mental disorder is associated with criminal reoffending, especially violent acts of offending. Features of mental disorder, psychosocial stresses, substance use disorder, and personality disorder combine to increase the risk of criminal recidivism. Clozapine, an atypical antipsychotic, is indicated in the treatment of patients with psychotic disorders. This article is the report of a community follow-up study of a matched control of those treated with clozapine (n = 41) and those treated with other antipsychotics (n = 21). Rates of reoffending behavior in the general, nonviolent, violent, and sexual categories were calculated after two years of follow-up. Although not statistically significant, the two-year criminal conviction rates of those treated with other antipsychotics in all offense categories except sexual reoffending were two-fold higher than in those treated with clozapine. The time from release to the first offense and crime-free time in the community were significantly longer in the clozapine group. By prolonging the time it takes from release to first offense, clozapine confers additional crime-reduction advantages.
authors.affiliation: Mansfield Mela is Associate Professor of Psychiatry, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. Dr. Gu Depiang is Research Associate, Correctional Services of Canada, Regional Psychiatric Centre, Saskatoon, Saskatchewan, Canada. Presented at the 44th annual meeting of the American Academy of Psychiatry and the Law, October 23-27, 2013, San Diego, CA. mansfieldmela@gmail.com.
authors.forename: Mansfield
authors.initials: M
authors.lastname: Mela
authors.affiliation: Mansfield Mela is Associate Professor of Psychiatry, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. Dr. Gu Depiang is Research Associate, Correctional Services of Canada, Regional Psychiatric Centre, Saskatoon, Saskatchewan, Canada. Presented at the 44th annual meeting of the American Academy of Psychiatry and the Law, October 23-27, 2013, San Diego, CA.
authors.forename: Gu
authors.initials: G
authors.lastname: Depiang
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use*; D003024:Clozapine / Q000627:therapeutic use*; D003415:Crime / Q000517:prevention & control*; D057237:Criminals / Q000331:legislation & jurisprudence*; D005500:Follow-Up Studies; D006801:Humans; D011618:Psychotic Disorders / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D003024:Clozapine